Aiforia Technologies Plc announced the release of Aiforia® Studies, a software module that offers AI-assisted image analysis workflow within the framework of Good Laboratory Practices (GLP). Aiforia® Studies is designed especially for pharmaceutical companies and contract research organizations engaged in non-clinical histology studies that need to adhere to GLP guidelines, although its application is not restricted to such studies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 EUR | +0.50% | +1.79% | +14.33% |
May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
Apr. 24 | Aiforia Signs A Contract with A Veterinary Health Company in the US | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.33% | 113M | |
+13.11% | 3,161B | |
+11.55% | 87.62B | |
+7.38% | 79.59B | |
-14.34% | 54.14B | |
+25.92% | 48.15B | |
-24.39% | 46.81B | |
+35.49% | 47.69B | |
+80.54% | 42B | |
-6.24% | 25.77B |
- Stock Market
- Equities
- AIFORIA Stock
- News Aiforia Technologies Oyj
- Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow